ACO, Health Insurance Exchange Pressures Mounting
As healthcare reform advances, experts say, dermatologists face mounting pressure to prove their mettle to insurance exchanges and accountable care organizations (ACOs).
Medical-Loss Ratio Prompted Insurers to Refund $332 Million Last Year
A federal rule requiring health insurers to spend a minimum percentage of premium dollars on medical care led to more than $332 million in rebates last year, according to HHS.
Robotics Do Not Reduce Complications in Bladder Surgery
Following the success of robotics in prostate surgeries, the technique was expected to provide comparable results for bladder cancer surgeries as well.
Gilead's Idelalisib Approved for CLL and Lymphoma
The drug has been approved for use in patient's with relapsed disease.
Cost-Conscious Payers Are Eyeing Higher Prices on Diabetes Drugs
With diabetes costs taking double-digit increases--and expensive newer meds launching--insurers are tightening restrictions on drug use.
Specialists See Little Change in Compensation, Survey Finds
According to a recent survey, radiation oncologists are doing this for 7.9% less pay than they earned the year before.
NICE Approves Xtandi and Yervoy
The approval is a big gain for melanoma (Yervoy) and prostate cancer (Xtandi) patients in England and Wales.
Entecavir Falls Short of Protecting Hep B-infected Patients from HCC
However, a point to note is that this was a small cohort study without a comparator arm.
Appeals Courts Disagree Over Obamacare
Obamacare got taken for a roller-coaster ride on Tuesday when two different appeals courts took completely different takes on the latest challenges to the law.
HHS Reissues Dsputed 340B Policy on Orphan-Drug Discounts
HHS issued an interpretive rule that requires drug companies to provide discounts on orphan drugs sold through a federal program just months after a judge struck down the government's previous version of the rule.
AJMC Study Finds Medicaid Barriers to the Right Drugs May Cause More with Schizophrenia to Land Behind Bars
A study in The American Journal of Managed Care finds Medicaid prior authorization requirements for newer antipsychotic drugs are associated with an increased likelihood that individuals with schizophrenia will be incarcerated for nonviolent drug offenses. The study comes amid media scrutiny over whether cutbacks in mental health actually save money, when other costs are taken into account.
IT, Patient-Centered Research Key to Pushing Disease Prevention Efforts
Information technology will be crucial to pushing disease prevention efforts in healthcare.
To Prevent Surprise Bills, New Health Law Rules Could Widen Insurer Networks
The Obama administration and state insurance regulators are developing stricter standards to address the concerns of consumers who say that many health plans under the Affordable Care Act have unduly limited their choices of doctors and hospitals, leaving them with unexpected medical bills.
Breakthrough Therapy Designation for Aduro's Immunooncology Combination for Pancreatic Cancer
Aduro joins the exclusive group of companies, so far only the big pharma, that have a successful trail of immunooncology candidates.
HPV Screen Better Predictor of Cervical Cancer Risk Than Pap Test
The researchers found that the risk of developing cervical cancer within three years following a negative HPV test result was about half of the already low risk following a negative Pap test.
Lawmakers Urge CMS to Extend MU Hardship Exception for Pathologists
Eighty-nine members of Congress have asked the Centers for Medicare & Medicaid Services to give pathologists a break and extend the hardship exemption they currently enjoy for all of Stage 3 of the Meaningful Use program.
Why Are Payers Concerned with Patient Engagement Strategies?
While healthcare organizations and providers are addressing strategies for engaging patient populations in the pursuit of incentive or value-based reimbursements, payers are actively looking for ways to engage this same population as consumers in the name of healthcare reform.
Personalized Medicine: It May be High Cost, but It’s Higher Value
Personalized medicine will be expensive in these early days of pioneering and planning. But individual genomic testing is not going to be exorbitant forever – and the ROI is gonna be big, both in patient outcomes and dollars saved.
In ACO Era, Physicians Will Still Play a Leading—But Changing—Role
More than 8 million Americans have signed up for health insurance thanks to the Patient Protection and Affordable Care Act. Significantly increasing access to care, the 4-year-old healthcare reform law also creates incentives for providers to reorganize the delivery of healthcare.
HCA Earnings Get Bigger Boost than Expected from Healthcare Reform
HCA, the country's largest for-profit hospital chain by revenue, Wednesday previewed strong second-quarter results, highlighting a 12.2% increase in income before taxes. It also raised its financial guidance for the year.
In the Literature: No Survival Advantage Following Mastectomy in Stage I or II BRCA-Negative Breast Cancer
Preventive mastectomy did not improve survival in the study population.
Kentucky Law Grants Prescribing Authority to Nurses
A new Kentucky state law that expands prescribing authority for advanced practice registered nurses took effect Tuesday, the same day that a study was published touting the benefits of having nurses manage care for patients with chronic conditions such as diabetes and high blood pressure.
Immunosignatures Could Replace Cancer Biomarkers in Early Diagnosis
The study, published in PNAS, showed that the peptide microarrays could classify complex heterogeneous cancers with upto 98% accuracy.